Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Valladeau

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Science Advances|January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapyPaola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.
Bioinformatics (Oxford, England)|October 16, 2025
IntegrAlign: a comprehensive tool for multi-immunofluorescence panel integration through image alignmentLeo Hermet, Leo Laoubi, Martial Scavino, et al.
Nature Communications|March 29, 2025
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2Candice Sakref, Alexis Saby, Céline Rodriguez, et al.
International Journal of Cancer|July 22, 2014
Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cellsFlorence Deauvieau, Vincent Ollion, Anne-Claire Doffin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissuesJenny Valladeau, Valérie Clair-Moninot, Colette Dezutter-Dambuyant, et al.
Science Immunology|April 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancerMargaux Hubert, Elisa Gobbini, Coline Couillault, et al.
Journal for Immunotherapy of Cancer|June 18, 2026
Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapyFélix K Pham, Marion Dufeu, Valentin Benboubker, et al.
European Journal of Immunology|January 9, 2023
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methodsFelix Bayerl, David A Bejarano, Giulia Bertacchi, et al.
Cancer Immunology Research|January 8, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with MelanomaElisa Gobbini, Margaux Hubert, Anne-Claire Doffin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2014
Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cellsSreekumar Balan, Vincent Ollion, Nicholas Colletti, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Science Advances|January 26, 2022
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapyPaola Bonaventura, Vincent Alcazer, Virginie Mutez, et al.
Bioinformatics (Oxford, England)|October 16, 2025
IntegrAlign: a comprehensive tool for multi-immunofluorescence panel integration through image alignmentLeo Hermet, Leo Laoubi, Martial Scavino, et al.
Nature Communications|March 29, 2025
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2Candice Sakref, Alexis Saby, Céline Rodriguez, et al.
International Journal of Cancer|July 22, 2014
Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cellsFlorence Deauvieau, Vincent Ollion, Anne-Claire Doffin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissuesJenny Valladeau, Valérie Clair-Moninot, Colette Dezutter-Dambuyant, et al.
Science Immunology|April 19, 2020
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancerMargaux Hubert, Elisa Gobbini, Coline Couillault, et al.
Journal for Immunotherapy of Cancer|June 18, 2026
Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapyFélix K Pham, Marion Dufeu, Valentin Benboubker, et al.
European Journal of Immunology|January 9, 2023
Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methodsFelix Bayerl, David A Bejarano, Giulia Bertacchi, et al.
Cancer Immunology Research|January 8, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with MelanomaElisa Gobbini, Margaux Hubert, Anne-Claire Doffin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 11, 2014
Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cellsSreekumar Balan, Vincent Ollion, Nicholas Colletti, et al.
Pageof 5